“…Majority of the patients included in the studies were identified to have bacterial meningitis, while some studies included those with fungal [8][9][10]12,13 and viral 11 Four studies correlated TCD monitoring findings with Glasgow Coma Scale (GCS), 8,9,11,12 while five studies correlated the outcomes with the Glasgow Outcomes Scale (GOS) 8,9,11,12,14 One study also determined the clinical status by the Scandinavian Stroke Scale (SSS) and the Hunt and Hess Scale (HH). 12 TCD findings were commonly assessed within 12 h after admission and serially on days 1, 3, 5, 8, 14, and 21. TCD devices varied among the studies, including the following: TC 2-64, EME (Überlingen, Germany); DWL (Sipplingen, Germany) Multidop X; 2 or 4 MHz probe (Multi-Dop X, DWL Elektronische Systeme GmbH, Uberlingen, Germany); 3.5 and 5 MHz transducers with an EUB 515 A scanner (Hitachi, Tokyo, Japan); SonaraTek Digital TCD, CareFusion, Middleton, WI or Lucid TCD, Neural Analytics, Los Angeles, CA.…”